Dr. Nicola Fameli, an Italian-born Canadian researcher from the University of British Columbia, who was awarded a Marie Curie International Incoming Fellowship under the European Union Framework Programme 7, shares his personal and professional experiences from his fellowship tenure.
DLR PT and its ERA-Can+ partners are helping European researchers access potential sources of European and Canadian funding. The information sessions feature presentations of Canadian Funding Programmes open to Europeans, EU/German cooperation initiatives towards Canada and shows best practice examples of EU/Germany – Canadian collaboration. The sessions are free of charge and open to everyone interested. Read more
BioSHaRE (Biobank Standardization and Harmonization for Research Excellence in the European Union), a Seventh Framework Programme (FP7) funded project (2010-2015), is a consortium of European leading biobanks and international researchers. BioSHaRE objectives were to develop data harmonization tools and standardized IT systems for existing biobanks and cohorts across Europe in order to conduct pan-European epidemiological research.
Within the IRTG 1830 on Complex Membrane Proteins in Development and Disease highly profiled researchers and young academics of two German universities (University of Kaiserslautern and Saarland University) and the University of Alberta at Edmonton (Canada) are investigating the role of membrane proteins in developmental processes and diseases such as immune mediated diseases, deafness, cystic fibrosis, cancer and cardiovascular dysfunction. It was the first joint training group for highly-qualified students from Germany and Canada in the life science area. In Germany, the programme is financed by the German Research Foundation (DFG) while the partner group in Canada receives funding from the Collaborative Research and Training Experiences Program (CREATE) of the Natural Sciences and Engineering Research Council of Canada (NSERC). Read more
Samuel’s project focuses on ultrasound detection of fatty liver disease (FLD). The disease can present as a result of factors such as obesity, diabetes, or alcohol consumption. Although patients with FLD don’t usually have symptoms, the disease can be fatal, making timely diagnosis critical. Read more
The Canadian Institutes of Health Research posted the following funding opportunity: